Welcome to our dedicated page for CACI INTERNATIONAL /DE/ SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CACI INTERNATIONAL /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CACI INTERNATIONAL /DE/'s regulatory disclosures and financial reporting.
CACI International Inc disclosed that its wholly owned subsidiary CACI, Inc. – Federal and certain other subsidiaries entered into Amendment No. 7 to the existing Master Accounts Receivable Purchase Agreement with MUFG Bank, Ltd. and certain purchasers. The amendment extends the agreement’s Scheduled Termination Date from December 19, 2025 to December 18, 2026 and also changes certain commercial terms of the arrangement. This keeps the company’s receivables purchase structure in place for an additional year under revised business provisions.
CACI International Inc agreed that its subsidiary CACI, Inc.-Federal will acquire ARKA Group, L.P. for an aggregate cash purchase price of $2.6 billion, subject to customary post-closing adjustments. The structure includes an initial purchase of partnership interests held by a blocker entity, followed by a merger of Spatium Merger Sub, LLC into ARKA Group, which will then become an indirect wholly owned subsidiary of CACI.
The agreement includes customary representations, warranties, covenants and closing conditions, including clearance under the Hart-Scott-Rodino Antitrust Improvements Act. The transaction may be terminated if it has not closed by June 19, 2026, subject to limited extension rights, and is expected to close in the third quarter of CACI’s 2026 fiscal year. CACI plans to fund the deal with cash on hand, borrowings under its revolving credit facility and additional debt, supported by a commitment from Wells Fargo for a senior secured bridge loan facility of up to $1.3 billion.
CACI has a Rule 144 notice covering a planned sale of its common stock.
A shareholder intends to sell 10168 shares of common stock through UBS Financial Services, Inc. on the NYSE, with an approximate sale date of 12/16/2025 and an aggregate market value of 5745326.00. The notice states that these 10168 shares were acquired on 10/01/2024 via RSU vestings from the issuer. It also lists 22079710 shares of this class outstanding.
CACI International Inc. director reports stock sale
A director of CACI International Inc. (CACI), William L. Jews, reported selling 3,000 shares of CACI common stock on 12/10/2025. The sale was reported at a price of $585.82 per share. After this transaction, he beneficially owns 3,384 CACI common shares in direct ownership. The filing is a standard Form 4 insider transaction report and does not include any derivative securities activity.
CACI has a security holder filing a notice of intent to sell 3,000 shares of common stock through broker Merrill at an aggregate market value of 1755225.46, with the sale expected on 12/10/2025 on the NYSE. Shares outstanding were 22,079,710, providing context for the size of the planned sale.
The shares planned for sale were originally acquired from CACI as stock compensation in multiple grants between 2015 and 2018, with individual awards ranging from 268 to 351 shares that together total 3,000 shares. By signing the notice, the seller represents that they are not aware of undisclosed material adverse information about CACI’s current or prospective operations.
CACI International Inc entered into a Second Amended and Restated Credit Agreement on November 25, 2025, replacing its prior 2021 facility. The agreement provides a $1.25 billion term loan facility and a $2.0 billion revolving credit facility, each maturing on November 25, 2030, with a $150.0 million swing line subfacility and a $25.0 million letter of credit subfacility. The company may add incremental debt within a detailed leverage- and coverage-based framework, including amounts tied to Consolidated EBITDA and specified leverage ratio thresholds. Obligations are secured by substantially all assets of CACI and its material domestic subsidiaries and are guaranteed by those subsidiaries, subject to customary exceptions. Interest on borrowings is based on a base rate or Term SOFR plus a margin set by the company’s Consolidated Total Net Leverage Ratio, and the agreement includes financial covenants on leverage and interest coverage, along with customary limitations on additional debt, liens, investments, asset transfers, dividends and certain transactions.
Morgan Stanley and Atlanta Capital Management Company, LLC filed Amendment No. 7 to Schedule 13G reporting beneficial ownership in CACI International Inc. as of 09/30/2025.
Morgan Stanley reported 1,551,022 shares beneficially owned, representing 7.1% of the common stock, with shared voting power 1,406,590 and shared dispositive power 1,494,434. Atlanta Capital reported 1,313,754 shares beneficially owned, representing 6.0%, with shared voting power 1,194,448 and shared dispositive power 1,261,289.
Both filers certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
CACI International (CACI) Chief Financial Officer Jeffrey D. MacLauchlan reported equity award vesting and related tax withholdings on 11/01/2025. He acquired 1,101 shares upon vesting of restricted stock units and 5,072 shares upon vesting of performance RSUs (both shown with code M). To cover taxes, the issuer withheld 541 shares and 2,488 shares at $562.25 per share (code F). Following these transactions, his directly held stake was 7,475 shares.
Footnotes state the RSUs were granted on November 1, 2022 and vest one-third per year over three years, while the PRSUs vested on the third anniversary based on a three‑year performance measure.
CACI International Inc reported first‑quarter results for the period ended September 30, 2025. Revenue was $2,287.6 million, up 11.2% year over year, driven by organic growth and program wins. Income from operations rose to $212.3 million (up 18%). Diluted EPS was $5.63 versus $5.33 a year ago, with net income of $124.8 million.
Operating cash flow strengthened to $171.1 million versus $34.7 million last year, aided by working capital. The company ended the quarter with cash of $133.0 million and long‑term debt (net of current portion) of $2,708.7 million. CACI has interest rate swaps covering $900.0 million of floating‑rate debt. As of October 17, 2025, common shares outstanding were 22,079,710.
Backlog reached $33.9 billion, and remaining performance obligations were $13.1 billion, with approximately 44% and 63% expected to convert to revenue over the next 12 and 24 months, respectively. Revenue mix included $1,300.7 million from Technology and $986.9 million from Expertise; Department of Defense revenue was $1,179.6 million. The company recorded no goodwill impairments. In legal matters, a jury entered a $42 million judgment in November 2024; CACI has appealed and recorded no amounts related to this case.
CACI International Inc filed an 8-K noting it has released financial results for its first quarter of fiscal year 2026. The company furnished a press release as Exhibit 99.1 and provided the schedule for a conference call and webcast on October 23, 2025.
The filing is administrative, serving to make the results announcement and call details publicly available. CACI’s common stock trades on the NYSE under the symbol CACI.